MONMOUTH JUNCTION, N.J. (AP) _ CytoSorbents Corp. (CTSO) on Tuesday reported a loss of $4.2 million in its first quarter.
On a per-share basis, the Monmouth Junction, New Jersey-based company said it had a loss of 10 cents.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.
The blood purification therapy company posted revenue of $10.6 million in the period, which also did not meet Street forecasts. Six analysts surveyed by Zacks expected $11.4 million.
CytoSorbents shares have risen 14% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.09, a decline of 3% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News